SCHEMBL6990853

SCHEMBL6990853

CCOC(=O)c1ccc(CC[C@H](O)CO[Si](C)(C)C(C)(C)C)s1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
ALDH1A1 P00352 3/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CDC7 O00311 1/20 0.34
DBF4 Q9UBU7 1/20 0.34
MAPT P10636 2/20 0.33
GAA P10253 1/20 0.33
NMT2 O60551 1/20 0.33
ADRB2 P07550 1/20 0.33
ADRB1 P08588 1/20 0.33
ADRB3 P13945 1/20 0.33
NMT1 P30419 1/20 0.33
KDM4E B2RXH2 2/20 0.33
TSHR P16473 2/20 0.33
HPGD P15428 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6990850 1.00 HDAC3 (0.42) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL6990188 0.83 HDAC3 (0.36) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL6990186 0.83 HDAC3 (0.36) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL6993227 0.83 HDAC3 (0.38) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL6993223 0.83 HDAC3 (0.38) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL29051983 0.81 HDAC3 (0.46) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL6989842 0.80 HDAC3 (0.47) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL8685062 0.78 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2MAPTGAANMT2
SCHEMBL6989769 0.76 HDAC3 (0.41) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL6989772 0.76 HDAC3 (0.41) HDAC3HDAC4HDAC1HDAC6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0846111-B1 SYNTHESES OF OPTICALLY PURE COMPOUNDS USEFUL AS GARFT INHIBITORS AND THEIR INTERMEDIATES AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-5981748-A Synthesis of optically pure compounds useful as GARFT inhibitors and their intermediates AGOURON PHARMACEUTICALS, INC. (US) 1999-11-09 US disclosed